Insider · CIK 0001936319
Mathias Hukkelhoven
Files at CGEN (COMPUGEN LTD), CNTA (Centessa Pharmaceuticals plc). First filing -, latest -.
In brief
Mathias Hukkelhoven files SEC Form 4 as director at CGEN (COMPUGEN LTD), and also at CNTA (Centessa Pharmaceuticals plc). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Mathias Hukkelhoven has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 7 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 29, 2026 | CGEN COMPUGEN LTD | AGrant or award Ordinary Shares | +7,500 | $0.00 | $0 | 17,500 | Jul 30, 2026 |
| Jul 29, 2026 | CGEN COMPUGEN LTD | AGrant or award Share Option (right to buy)derivative | +10,000 | $0.00 | $0 | 10,000 | Jul 30, 2026 |
| Jun 24, 2026 | CNTA Centessa Pharmaceuticals plc | DDisposition to issuer Share Option (right to buy)derivative | -96,000 | - | - | 0 | Jun 24, 2026 |
| Jun 24, 2026 | CNTA Centessa Pharmaceuticals plc | DDisposition to issuer Share Option (right to buy)derivative | -48,000 | - | - | 0 | Jun 24, 2026 |
| Jun 24, 2026 | CNTA Centessa Pharmaceuticals plc | DDisposition to issuer Share Option (right to buy)derivative | -48,000 | - | - | 0 | Jun 24, 2026 |
| Jun 24, 2026 | CNTA Centessa Pharmaceuticals plc | DDisposition to issuer Share Option (right to buy)derivative | -40,000 | - | - | 0 | Jun 24, 2026 |
| Jun 20, 2025 | CNTA Centessa Pharmaceuticals plc | AGrant or award Share Option (right to buy)derivative | +40,000 | $0.00 | $0 | 40,000 | Jun 24, 2025 |
Questions about Mathias Hukkelhoven
Answered from the filings on this page, as of the latest one.
Is Mathias Hukkelhoven buying or selling?
Mathias Hukkelhoven has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Mathias Hukkelhoven's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Mathias Hukkelhoven has 0.
Where does Mathias Hukkelhoven file Form 4?
Mathias Hukkelhoven has filed Form 4 at CGEN (COMPUGEN LTD); CNTA (Centessa Pharmaceuticals plc). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.